A case study demonstrates that affinity chromatography can offer efficiency and scalability for gene therapy manufacturing using viral vectors.
Frank Detmers
Advertisement
Frank Detmers is Director of Ligand Applications, Bioproduction at Thermo Fisher Scientific (Leiden, The Netherlands)
Articles by Frank Detmers
Advertisement
Latest Updated Articles
Affinity Chromatography Accelerates Viral Vector Purification for Gene TherapiesPublished: September 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
5
